PKD2 and breast carcinoma: Silencing PKD2 significantly decreased cell proliferation of HCC1806 breast cancer cells,23 while a report claimed that PKD2 expression level was reduced in triple‐negative breast cancer.22 Whether and how PKD2 functions in breast cancer is still obscure.